Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global Anaplastic Lymphoma Kinase (ALK) Inhibitors Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The anaplastic lymphoma…
– Clinical results conclusively demonstrate that BLU-5937, a highly selective P2X3 antagonist, is a differentiated product candidate that has little…
Columbia Care and Westmed testing precisely formulated cannabis-based drugs can relieve pain from arthritis
Seattle Genetics has announced the appointment ofRobin G. Taylor, M.B.A., Ph.D., as Chief Commercial Officer
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/NGS?src=hash" target="_blank"gt;#NGSlt;/agt;–Oncologica, a leading precision oncology profiling company and Contract Research Organization (CRO), has chosen Arkivum to provide…
DUBLIN–(BUSINESS WIRE)–The “Global Attention-Deficit Hyperactivity Disorder (ADHD) Market: Size, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s offering.…
Xcenda,a part of AmerisourceBergen, today announced the acquisition ofDymaxium, a trusted market access partner specializing in the exchangeof evidence and information between payers and life science companiesthrough its FormularyDecisions.com® platform.
Debiopharm has enrolled first patient in SMARTPLUS-106, a Phase lb/II study in patients failing prior PD-1/PD-L1 treatment in selected solid tumors.
The development of the UK’s first dedicated Vaccines Manufacturing Innovation Centre (VMIC) has moved a step closer with the contract to design an advanced array of laboratory and production facilities within a ‘cleanroom wrap’ environment being awarded to WHP, the company has said in a statement.
Japanese government organization to train reviewers to efficiently analyze PBPK model submissions LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), the…